DE602006016830D1 - Derivate von 2-aminthiazolen und 2-aminooxazolen, verfahren zu deren darstellung und deren verwendung als arzneimittel - Google Patents

Derivate von 2-aminthiazolen und 2-aminooxazolen, verfahren zu deren darstellung und deren verwendung als arzneimittel

Info

Publication number
DE602006016830D1
DE602006016830D1 DE602006016830T DE602006016830T DE602006016830D1 DE 602006016830 D1 DE602006016830 D1 DE 602006016830D1 DE 602006016830 T DE602006016830 T DE 602006016830T DE 602006016830 T DE602006016830 T DE 602006016830T DE 602006016830 D1 DE602006016830 D1 DE 602006016830D1
Authority
DE
Germany
Prior art keywords
aminthiazolen
aminooxazoles
medicament
derivatives
representation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006016830T
Other languages
English (en)
Inventor
Stefanie Keil
Matthias Urmann
Maike Glien
Wolfgang Wendler
Karen Chandross
Lan Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE602006016830D1 publication Critical patent/DE602006016830D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602006016830T 2005-09-29 2006-09-26 Derivate von 2-aminthiazolen und 2-aminooxazolen, verfahren zu deren darstellung und deren verwendung als arzneimittel Active DE602006016830D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05021279 2005-09-29
PCT/EP2006/009302 WO2007039176A1 (en) 2005-09-29 2006-09-26 Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
DE602006016830D1 true DE602006016830D1 (de) 2010-10-21

Family

ID=35764446

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006016830T Active DE602006016830D1 (de) 2005-09-29 2006-09-26 Derivate von 2-aminthiazolen und 2-aminooxazolen, verfahren zu deren darstellung und deren verwendung als arzneimittel

Country Status (20)

Country Link
US (1) US7655679B2 (de)
EP (1) EP1931659B1 (de)
JP (1) JP2009509987A (de)
KR (1) KR20080048510A (de)
CN (1) CN101277953A (de)
AR (1) AR056542A1 (de)
AT (1) ATE480536T1 (de)
AU (1) AU2006299090A1 (de)
BR (1) BRPI0616477A2 (de)
CA (1) CA2624100A1 (de)
DE (1) DE602006016830D1 (de)
IL (1) IL190230A0 (de)
MA (1) MA29806B1 (de)
MY (1) MY148883A (de)
NO (1) NO20081368L (de)
NZ (1) NZ566876A (de)
RU (1) RU2008112199A (de)
TW (1) TW200732328A (de)
UY (1) UY29832A1 (de)
WO (1) WO2007039176A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100097170A (ko) 2007-11-20 2010-09-02 스미또모 가가꾸 가부시키가이샤 피리딘 화합물, 유해 생물 방제 조성물 및 유해 생물의 방제 방법
US9073881B2 (en) 2011-09-23 2015-07-07 Hoffmann-La Roche Inc. Benzoic acid derivatives
WO2013066839A2 (en) * 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
MX2021014410A (es) 2019-05-31 2022-03-17 Avolynt Composiciones y métodos para tratar la enfermedad metabólica.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641796A (en) 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
GB9919413D0 (en) 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds
JP4383177B2 (ja) * 2002-03-01 2009-12-16 スミスクライン ビーチャム コーポレーション ｈＰＰＡＲ活性化剤
US6653334B1 (en) 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
EP1586573B1 (de) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika

Also Published As

Publication number Publication date
WO2007039176A1 (en) 2007-04-12
TW200732328A (en) 2007-09-01
EP1931659B1 (de) 2010-09-08
MA29806B1 (fr) 2008-09-01
NO20081368L (no) 2008-06-18
CA2624100A1 (en) 2007-04-12
EP1931659A1 (de) 2008-06-18
BRPI0616477A2 (pt) 2011-06-21
US7655679B2 (en) 2010-02-02
IL190230A0 (en) 2008-11-03
JP2009509987A (ja) 2009-03-12
KR20080048510A (ko) 2008-06-02
ATE480536T1 (de) 2010-09-15
MY148883A (en) 2013-06-14
AU2006299090A1 (en) 2007-04-12
CN101277953A (zh) 2008-10-01
RU2008112199A (ru) 2009-10-10
AR056542A1 (es) 2007-10-10
US20080227834A1 (en) 2008-09-18
UY29832A1 (es) 2007-04-30
NZ566876A (en) 2010-05-28

Similar Documents

Publication Publication Date Title
DE502005010912D1 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE502005007786D1 (de) Ausgewahlte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE602007000632D1 (de) Laserinterferometer, sowie Verfahren zu dessen Kalibrierung und Verwendung
DE602005015699D1 (de) Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
ATE556077T1 (de) Tetrahydrochinolinderivate und verfahren zu deren herstellung
ATE482207T1 (de) Cyclische harnstoffderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung als kinaseinhibitoren
ATE470666T1 (de) Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50312949D1 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
DE602008006045D1 (de) Heterocyclische verbindungen, zusammensetzungen damit und verfahren zu ihrer anwendung
DE502004002117D1 (de) Substituierte thiazol-benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung
DE502005010105D1 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
ATE433958T1 (de) Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung
DE602005003648D1 (de) Derivate von alkylpiperazin- und alkylhomopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
EP1877068A4 (de) Nicotinamidribosid-kinase-zusammensetzungen und verfahren zu deren verwendung
ATE471938T1 (de) Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten
DE602004029245D1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
DE602005015506D1 (de) Filmzubereitung und Verfahren zu deren Herstelllung
ATE535510T1 (de) Benzylamine, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmende mittel
DE602004010229D1 (de) Polyenpolyketide, verfahren zu deren herstellung und deren verwendung als pharmazeutikum
DE602005001930D1 (de) Derivate vom aryloxyalkylcarbamat-typ, verfahren zu deren herstellung und deren verwendung in therapeutika
EP1948828A4 (de) Multimerische biosensoren und verfahren zu deren verwendung
ATE509923T1 (de) Derivate von 7-alkynyl-1,8-naphthyridonen, verfahren zu ihrer herstellung und ihre verwendung in therapeutika
EP1873798A4 (de) Kondensator und verfahren zu seiner herstellung
DE112004002104A5 (de) Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
DE602005018911D1 (de) 1,4-Dihydropyridine-kondensierte Heterocyclen Verfahren zu deren Herstellung sowie Verwendung und Zusammensetzungen dergleichen